Liver Transplant Rejection
📧 Sign up to get email alerts when something new happens for Liver Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients [Phase 1, Phase 2]
Phase 1/2 data on QEL-001 in A2-mismatch liver transplant patients show safety and preliminary clinical activity in the setting of transplan…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
Clinical trial NCT06153641 investigates cytokeratin 18 as a non-invasive biomarker for liver transplant rejection; the study is currently ac…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension [Phase 2]
A Phase 2 study of CFZ533, an anti-CD40 monoclonal antibody, in liver transplant recipients was terminated, with results including 12-month …
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients [Phase 4]
Phase 4 clinical trial assessing erythropoietin therapy to induce regulatory T cells in liver transplant recipients with rejection.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Budesonide for Liver Transplant Immune Suppression [Phase 2]
Phase 2 clinical trial evaluating budesonide for liver transplant immune suppression has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial [NA]
A single-center randomized trial compares two prolonged-release tacrolimus variants (Advagraf vs Envarsus) to evaluate safety and efficacy a…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating intraportal infusion of autologous bone marrow mononuclear cells t…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
This study evaluates immune tolerance and alloreactivity in liver transplant recipients treated with different single-agent immunosuppressan…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation
A completed trial evaluating whether serial changes in anti-donor lymphocyte antibodies influence graft rejection or tolerance after liver t…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients. [Phase 3]
A Phase 3 randomized trial comparing Prograf and Prograf-XL in de novo liver transplant recipients has completed.